Growth hormone and childhood-onset craniopharyngioma: When to initiate growth hormone replacement therapy?
Adrien Nguyen QuocKévin BeccariaLaura González BriceñoGraziella PintoDinane Samara-BoustaniAthanasia StoupaJacques BeltrandAlix BesançonCaroline ThalassinosStéphanie PugetThomas BlauwblommeClaire AlapetiteStéphanie BolleFrançois DozJacques GrillChristelle DufourFranck BourdeautSamuel AbbouLéa Guerrini-RousseauAmaury LerusteSéverine BrabantIphigénie CavadiasMagali ViaudNathalie BoddaertMichel PolakDulanjalee KariyawasamPublished in: The Journal of clinical endocrinology and metabolism (2023)
No association was found between GHRT time delay after childhood-onset craniopharyngioma treatment and an increased risk of recurrence or tumour progression, suggesting GH replacement therapy can be initiated 6 months after last treatment for craniopharyngiomas.